Select Publications
Journal articles
, 2000, 'The β-galactosidase gene as a marker for hematopoietic reconstitution: Individual cell analysis in a murine bone marrow transplantation model', Journal of Hematotherapy and Stem Cell Research, 9, pp. 659 - 672, http://dx.doi.org/10.1089/15258160050196704
, 2000, 'Induced p21(WAF1) expression acts to reverse myc myelomonocytic cell transformation', Cancer Gene Therapy, 7, pp. 1491 - 1503, http://dx.doi.org/10.1038/sj.cgt.7700229
, 2000, 'Induced p21 WAF1 expression acts to reverse myc myelomonocytic cell transformation', Cancer Gene Therapy, pp. 1492 - 1503
, 2000, 'Induced p21 WAFI expression acts to reverse myc myeoomomocytic cell transformation', Cancer Gene Therapy, pp. 1492 - 1503
, 2000, 'The beta-galactosidase gene as a marker for hematopoietic reconstitution: individual cell analysis in a murine bone marrow transplantation', Journal of Hematotherapy and Stem Cell Research, pp. 659 - 672
, 2000, 'The beta-galactosidase gene as a marker for hematopoietic reconstitution: individual cell analysis in a muring bone marrow transplantation', Journal of Hematotherapy and Stem Cell Research, pp. 659 - 672
, 1999, 'Mutant N-ras induces myeloproliferative disorders and apoptosis in bone marrow repopulated mice', Blood, pp. 2043 - 2056
, 1998, 'V-myc in a simple, single gene retroviral vector causes rapid induction of leukemia and concomitant apoptosis following bone marrow transplantation', Leukemia, 12, pp. 542 - 553
, 1997, 'Myeloproliferative disease and myelodysplastic syndrome induced by transplantation of bone marrow cells expressing mutant p53', Leukemia, 11, pp. 1641 - 1649, http://dx.doi.org/10.1038/sj.leu.2400782
, 1997, 'Enhanced preservation of the rat heart after prolonged hypothermic storage with the21-aminosteriod U74500A', Asia Pacific Heart Journal, 6, pp. 184 - 189, http://dx.doi.org/10.1016/S1328-0163(97)90028-2
, 1996, 'Retroviral transduction of hematopoietic progenitor cells with mutant p53 promotes survival and proliferation, modifies differentiation potential and inhibits apoptosis', Leukemia, 10, pp. 1619 - 1628
, 1996, 'Apoptosis in v-myc transformation of myelomonocytic cells and its modulation by CSF-1', Oncogene, 12, pp. 1189 - 1198
, 1996, 'Ribozyme-mediated suppression of v-myc expression abrogates apoptosis in transformed monocytes', Cancer Gene Therapy, pp. 289 - 295
, 1995, 'Mutant p53 transformation of murine bone marrow-derived hematopoietic cells.', BLOOD, 86, pp. 4021 - 4021, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1995TH91004021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 1995, 'Transformation by v-erb-B: induction of apoptosis is abrogated in a myeloid cell line', International Journal of Oncology, 6, pp. 633 - 638
, 1993, 'Heat‐shock gene expression and cell cycle changes during mammalian embryonic development', Developmental Genetics, 14, pp. 127 - 136, http://dx.doi.org/10.1002/dvg.1020140207
Conference Papers
, 2021, 'Patient-derived xenograft mouse models to test novel cell therapies for leukemia', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY, pp. 12 - 13, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000693805000014&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2017, 'Preclinical optimization of a low cost PiggyBac transposase (PB) generated CD19-specific chimeric antigen receptor T cell (CART19) product for a first in man trial using local hospital cell manufacture', in CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, DC, Washington, presented at
, 2016, 'Combined immune and epigenetic therapy for high risk and relapsed leukaemias and lymphomas', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 118 - 119, presented at
, 2016, 'Ex vivo expansion of cytolitic natural killer cells in combined immune therapy for relapsed and refractory neuroblastoma', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 131 - 131, presented at
, 2016, 'Haematopoietic stem cells to generate chimeric antigen receptor (CAR)-modified T cells', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 119 - 119, presented at
, 2016, 'Increasing stem cell dose promotes immune reconstitution following stem cell transplant', in EUROPEAN JOURNAL OF IMMUNOLOGY, WILEY-BLACKWELL, AUSTRALIA, Melbourne, pp. 954 - 954, presented at
, 2016, 'HAEMATOPOIETIC STEM CELL TRANSPLANTS ENHANCE CART CELL EXPANSION AND PERSISTENCE IN XENOGRAFT MOUSE MODEL', in CYTOTHERAPY, ELSEVIER SCI LTD, pp. S61 - S61, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376222800162&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2015, 'DECLINED PRESENTATION ONE DOSE OF 5-AZA-2 '-DEOXYCYTIDINE ENHANCES THERAPEUTIC EFFICACY OF CART-CELL THERAPY IN A MURINE MODEL BY IMPROVING T-CELL PERSISTENCE', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Kyoto, pp. S59 - S59, presented at
, 2015, 'DECLINED PRESENTATION STEM CELL APPROACH TO GENERATE CHIMERIC ANTIGEN RECEPTOR MODIFIED IMMUNE EFFECTOR CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Kyoto, pp. S59 - S59, presented at
, 2015, 'DECLINED PRESENTATION T-CELL PRECURSORS TO GENERATE CHIMERIC ANTIGEN RECEPTOR (CAR)-MODIFIED T CELLS', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, JAPAN, Kyoto, pp. S60 - S60, presented at
, 2014, '5-Aza-2 '-Deoxycytidine Promotes Cytotoxic Effect of CART-Cells on Leukaemia Cells', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at
, 2014, 'Stem Cell Approach to Generate Chimeric Antigen Receptor Modified Immune Effector Cells to Treat Cancer', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, presented at
, 2014, 'STEM CELL APPROACH TO GENERATE MULTIPLE IMMUNE EFFECTOR CELLS TO TREAT CANCER', in ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, WILEY-BLACKWELL, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000344745100081&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2014, 'INCREASING STEM CELL DOSE PROMOTES THE LONGEVITY OF THE GRAFT IN MICE TRANSPLANTED WITH HUMAN CORD BLOOD STEM CELLS', in CYTOTHERAPY, ELSEVIER SCI LTD, pp. S57 - S57, http://dx.doi.org/10.1016/j.jcyt.2014.01.206
, 2013, 'GSK-3 beta INHIBITION PROMOTES T CELL RECONSTITUTION AND PRESERVES NAIVE T CELL PHENOTYPE IN MICE TRANSPLANTED WITH HUMAN HAEMATOPOIETIC STEM CELLS', in CYTOTHERAPY, INFORMA HEALTHCARE, pp. S6 - S6, http://dx.doi.org/10.1016/j.jcyt.2013.01.020
, 2013, 'TRANSIENT INHIBITION OF GSK-3,beta PROMOTES EARLY AND LATE ENGRAFTMENT OF EX VIVO EXPANDED HAEMATOPOIETIC PROGENITOR CELLS IN IMMUNO-COMPROMISED MICE', in CYTOTHERAPY, INFORMA HEALTHCARE, pp. S22 - S22, http://dx.doi.org/10.1016/j.jcyt.2013.01.081
, 2011, 'THE POTENTIAL OF GSK3B INHIBITORS AS NOVEL THERAPEUTICS FOR GVHD', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, pp. S22 - S23, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293801700045&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2011, 'THERAPEUTIC TARGETING OF GSK3B MAY BECOME A STRATEGY IN PATIENTS RECEIVING STEM CELL TRANSPLANTATION FOR HEMATOLOGIC MALIGNANCIES', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, pp. S81 - S82, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000293801700136&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2010, 'GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS SUPPRESS LEUKEMIA CELL GROWTH', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S48 - S48, presented at
, 2010, 'INVESTIGATING THE POTENTIAL OF PHARMACOCHEMICAL INHIBITION OF GSK3-BETA TO REDUCE THE BURDEN OF GVHD AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION', in EXPERIMENTAL HEMATOLOGY, ELSEVIER SCIENCE INC, AUSTRALIA, Melbourne, pp. S35 - S35, presented at
, 2008, 'GSK-3 beta Inhibition Activates WNT, Delays Division and Preserves the Function in Hematopoietic Stem Cell', in BLOOD, AMER SOC HEMATOLOGY, CA, San Francisco, pp. 230 - 230, presented at
, 2006, 'Glycogen synthase kinase-3 beta regulates ex-vivo expansion and engraftment of umbilical cord blood hematopietic stem cells through the activation of wnt signaling.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 105A - 106A, presented at
, 2006, 'Mutant Ras-expressing fibroblasts induce expansion of circulating angio- and lymphangiogenic precursor cells: Potential role in tumour vascularisation.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 389A - 389A, presented at
, 2006, 'N-ras(m)-transduced fibroblasts facilitate the expansion and engraftment of umbilical cord blood stem cells.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 912A - 912A, presented at
, 2006, 'Novel role of activated ras in leukaemogenesis: Induction of angiogenesis.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 385A - 385A, presented at
, 2006, 'Targeting the IRF2 transcription factor to inhibit leukaemic cell growth.', in BLOOD, AMER SOC HEMATOLOGY, FL, Orlando, pp. 414A - 414A, presented at
, 2006, 'Glycogen synthase kinase-3 regulates ex vivo expansion of human umbilical cord blood progenitor cells.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600054&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Molecular profile and functional analysis of the molecular factors derived from ras-transduced cells that regulate hematopoiesis.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600259&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Novel approaches for the ex vivo expansion of the engraftable cord blood derived haematopoietic progenitor cells.', in CYTOTHERAPY, TAYLOR & FRANCIS AS, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600043&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2006, 'Stroma cells support ex vivo expansion of retrovirally transduced haematopoietic progenitor cells.', in CYTOTHERAPY, INFORMA HEALTHCARE, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239337600010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
, 2005, 'Ras promotes engraftment of human haematopoietic stem cells through the activation of auto/paracrine mechanisms', in CYTOMETRY PART A, WILEY-LISS, AUSTRIA, Queensland, pp. 407 - 407, presented at
, 2005, 'Using a novel inhibitor of GSK-3 beta to activate the Wnt pathway in human haematopoietic stem cells: Impact on stem cell parameters', in CYTOMETRY PART A, WILEY-LISS, AUSTRIA, Queensland, pp. 415 - 416, presented at
, 2005, 'An in vivo assay for retrovirally transduced human haematopoietic stem/progenitor cells (HSC/HPC) using nonobese diabetic/severe combined immunodeficiency (NOD/SCID) mice', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, AUSTRALIA, Melbourne, pp. 1135 - 1135, presented at
, 2003, 'Differential retroviral transduction of primitive hematopoietic progenitors rather than gene silencing accounts for variation in transgene expression', in JOURNAL OF GENE MEDICINE, JOHN WILEY & SONS LTD, AUSTRALIA, QUEENSLAND INST MED RES BRISBANE, BRISBANE, pp. S13 - S14, presented at